Key Highlights:
- Aragen has launched ChemiSHE, a women-led chemistry synthesis lab at its Hyderabad facility, marking a first-of-its-kind initiative in India to be entirely operated by women scientists
- The lab will start with 12–14 scientists and aims to enhance leadership opportunities, research ownership, and visibility for women in pharmaceutical R&D
- As part of its broader diversity strategy, Aragen plans to add 800–1,000 women employees over the next three years, strengthening gender representation across scientific and leadership roles
Implications:
Aragen is using ChemiSHE to make gender diversity a visible part of its R&D operating model: an all‑women chemistry synthesis lab in Hyderabad, starting with 12–14 scientists and designed to give women greater ownership of projects and clearer leadership pathways.
A first‑of‑its‑kind inclusion initiative in India’s CRDMO space, coupled with a pledge to hire 800–1,000 additional women over three years across scientific and leadership roles, turning diversity into a strategic lever for talent attraction, innovation credentials, and global sponsor alignment on ESG.
Source: Aragen | Image: Aragen
